Membrane proteinase 3 expression on resting neutrophils as a pathogenic factor in PR3-ANCA-associated vasculitisVAN ROSSUM, A. P; LIMBURG, P. C; KALLENBERG, C. G. M et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 6, pp S64-S68, issn 0392-856X, SUP32Article

IgG subclass distribution of auto antibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosusBIJL, M; DIJSTELBLOEM, H. M; OOST, W. W et al.Rheumatology (Oxford. Print). 2002, Vol 41, Num 1, pp 62-67, issn 1462-0324Article

Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseasesROOZENDAAL, C; DE JONG, M. A; VAN DEN BERG, A. P et al.Journal of hepatology. 2000, Vol 32, Num 5, pp 734-741, issn 0168-8278Article

Pathophysiology of ANCA-associated glomerulonephritisKOBOLD, A. C. M; VAN DER GELD, Y. M; LIMBURG, P. C et al.Nephrology, dialysis, transplantation (Print). 1999, Vol 14, Num 6, pp 1366-1375, issn 0931-0509Article

Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritisFRANSSEN, C. F. M; STEGEMAN, C. A; OOST-KORT, W. W et al.Journal of the American Society of Nephrology. 1998, Vol 9, Num 10, pp 1915-1923, issn 1046-6673Article

Induction of tumor necrosis factor-α as a cause of bleomycin-related toxicitySLEIJFER, S; VUJASKOVIC, Z; LIMBURG, P. C et al.Cancer. 1998, Vol 82, Num 5, pp 970-974, issn 0008-543XArticle

High plasma tumor necrosis factor (TNF)-α concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolate limb perfusion with recombinant TNF-α, interferon-γ, and melphalanZWAVELING, J. H; MARING, J. K; CLARKE, F. L et al.Critical care medicine. 1996, Vol 24, Num 5, pp 765-770, issn 0090-3493Article

Association of autoantibodies to myeloperoxidase with different forms of vasulitisTERVAERT, J. W; GOLDSCHMEDING, R; VON DEM BORNE, A. E. G et al.Arthritis and rheumatism. 1990, Vol 33, Num 8, pp 1264-1272, issn 0004-3591, 9 p.Article

Changes in plasma levels of interleukin-2 receptors in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosusTER BORG, E. J; HORST, G; LIMBURG, P. C et al.Clinical and experimental immunology (Print). 1990, Vol 82, Num 1, pp 21-26, issn 0009-9104, 6 p.Article

B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue diseaseKALLENBERG, C. G. M; VAN DISSEL-EMILIANI, F; HUITEMA, M. G et al.Journal of clinical & laboratory immunology. 1988, Vol 26, Num 2, pp 55-61, issn 0141-2760Article

The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytesMOSHAGE, H. J; ROELOFS, H. M. J; VAN PELT, J. F et al.Biochemical and biophysical research communications (Print). 1988, Vol 155, Num 1, pp 112-117, issn 0006-291XArticle

In vitro T-cell dependent B-cell activity in myasthenia gravisLIMBURG, P. C; HUMMEL-TAPPEL, E; OOSTERHUIS, H. J et al.Clinical and experimental immunology (Print). 1985, Vol 61, Num 1, pp 31-38, issn 0009-9104Article

Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patientsFLEEFMAN, E; KUIPER, H; LIMBURG, P. C et al.Annals of the rheumatic diseases. 2008, Vol 67, Num 1, pp 11-18, issn 0003-4967, 8 p.Article

Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytesREEFMAN, E; KUIPER, H; JONKMAN, M. F et al.Rheumatology (Oxford. Print). 2006, Vol 45, Num 5, pp 538-544, issn 1462-0324, 7 p.Article

Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblastsWESTRA, J; LIMBURG, P. C; DE BOER, P et al.Annals of the rheumatic diseases. 2004, Vol 63, Num 11, pp 1453-1459, issn 0003-4967, 7 p.Article

Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reactionBIJL, M; BOOTSMA, H; VAN DER GELD, Y et al.Annals of the rheumatic diseases. 2004, Vol 63, Num 7, pp 831-835, issn 0003-4967, 5 p.Article

In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidasePOPA, E. R; FRANSSEN, C. F. M; LIMBURG, P. C et al.Arthritis and rheumatism. 2002, Vol 46, Num 7, pp 1894-1904, issn 0004-3591Article

Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE)BIJL, M; HORST, G; LIMBURG, P. C et al.Clinical and experimental immunology (Print). 2001, Vol 123, Num 1, pp 127-132, issn 0009-9104Article

Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytesBIJL, M; HORST, G; LIMBURG, P. C et al.European journal of clinical investigation. 2001, Vol 31, Num 6, pp 550-553, issn 0014-2972Article

Prediction of relapses in wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels : A prospective studyBOOMSMA, M. M; STEGEMAN, C. A; VAN DER LEIJ, M. J et al.Arthritis and rheumatism. 2000, Vol 43, Num 9, pp 2025-2033, issn 0004-3591Article

Serum levels of matrix metalloproteinase-3 in relation to the development of radiological damage in patients with early rheumatoid arthritisPOSTHUMUS, M. D; LIMBURG, P. C; WESTRA, J et al.Rheumatology (Oxford. Print). 1999, Vol 38, Num 11, pp 1081-1087, issn 1462-0324Article

Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodiesVAN DER GELD, Y. M; LIMBURG, P. C; KALLENBERG, C. G. M et al.Clinical and experimental immunology (Print). 1999, Vol 118, Num 3, pp 487-496, issn 0009-9104Article

Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patientsSCHIRM, J; KOOISTRA, A; VAN SON, W. J et al.Journal of clinical virology. 1999, Vol 14, Num 3, pp 153-165, issn 1386-6532Article

T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG)BROUWER, E; STEGEMAN, C. A; HUITEMA, M. G et al.Clinical and experimental immunology (Print). 1994, Vol 98, Num 3, pp 448-453, issn 0009-9104Article

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseasesMULDER, A. H. L; HORST, G; HAAGSMA, E. B et al.Hepatology (Baltimore, Md.). 1993, Vol 17, Num 3, pp 411-417, issn 0270-9139Article